retatrutide kidney function Tirzepatide vs. Retatrutide: Key Differences Explained Diagram showing the mechanism of

Implications for resistance training

Specifically, GIP is synthesized by the K cells in the upper intestine, while GLP-1 is generated by the L cells in the lower intestine

KAI-9531 is Kailera's lead injectable asset, a long-acting GLP-1/GIP/glucagon triple receptor agonist designed for once-weekly subcutaneous administration

GLP-1 medications work by slowing gastric emptying and increasing feelings of fullnessthat's their mechanism of action

Trademark Acknowledgment: Hello100 and any associated product names referenced in this article are trademarks or brand names of their respective owner

Given the complex, precise and coordinated steps involved in the physiology of gastric emptying, factors that may affect this sequential process can impact gastric motility in diabetics